QIX Deutschland
16.304,61
PKT
+55,17
PKT
+0,34
%
Werbung
Analysen zu QIX Deutschland-Werten
Datum | Rating | Analyst | |
---|---|---|---|
09.10.17 | SAP buy | Baader Bank | |
09.10.17 | SAP overweight | Barclays Capital | |
09.10.17 | SAP Outperform | Credit Suisse Group | |
09.10.17 | Deutsche Börse buy | HSBC | |
06.10.17 | Merck Neutral | JP Morgan Chase & Co. | |
06.10.17 | Software buy | UBS AG | |
06.10.17 | SAP Neutral | UBS AG | |
06.10.17 | SAP overweight | Morgan Stanley | |
06.10.17 | Covestro Underperform | BNP PARIBAS | |
06.10.17 | Evonik Neutral | BNP PARIBAS | |
06.10.17 | Hannover Rück Hold | Jefferies & Company Inc. | |
06.10.17 | Software Sell | Société Générale Group S.A. (SG) | |
05.10.17 | Merck Halten | Independent Research GmbH | |
05.10.17 | SAP Hold | Commerzbank AG | |
05.10.17 | Evonik Hold | Kepler Cheuvreux | |
05.10.17 | Evonik Outperform | Bernstein Research | |
05.10.17 | Software Sell | Goldman Sachs Group Inc. | |
04.10.17 | SAP overweight | Morgan Stanley | |
04.10.17 | Merck buy | Kepler Cheuvreux | |
04.10.17 | DHL Group (ex Deutsche Post) buy | Commerzbank AG | |
04.10.17 | Gerresheimer Neutral | Goldman Sachs Group Inc. | |
04.10.17 | CANCOM buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
02.10.17 | Evonik Halten | DZ BANK | |
02.10.17 | CANCOM buy | Hauck & Aufhäuser Privatbankiers KGaA | |
02.10.17 | Henkel vz. Sell | UBS AG | |
02.10.17 | Covestro buy | Deutsche Bank AG | |
02.10.17 | Hannover Rück Hold | Deutsche Bank AG | |
02.10.17 | Symrise buy | Deutsche Bank AG | |
02.10.17 | Merck buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
02.10.17 | DHL Group (ex Deutsche Post) buy | HSBC | |
29.09.17 | Merck buy | Warburg Research | |
29.09.17 | Merck buy | Citigroup Corp. | |
29.09.17 | Software buy | UBS AG | |
29.09.17 | Merck buy | UBS AG | |
29.09.17 | Merck buy | Oddo BHF | |
29.09.17 | Merck Neutral | JP Morgan Chase & Co. | |
29.09.17 | DHL Group (ex Deutsche Post) Halten | Independent Research GmbH | |
29.09.17 | Merck Hold | Commerzbank AG | |
29.09.17 | Evonik overweight | Barclays Capital | |
29.09.17 | Fresenius Medical Care (FMC) St. Conviction Buy List | Goldman Sachs Group Inc. |